Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hayden

Showing results (711-720 of 1,032) with videos related to

Pageof 104
Sort By:
Journal of Molecular and Cellular Cardiology|July 1, 1996
Post-transcriptional regulation of extracellular matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathyS C Tyagi, S G Kumar, S J Haas, et al.
American Journal of Nephrology|October 5, 2007
Insulin resistance, oxidative stress, and podocyte injury: role of rosuvastatin modulation of filtration barrier injuryAdam Whaley-Connell, Vincent G DeMarco, Guido Lastra, et al.
Human Molecular Genetics|April 25, 2002
Targeted disruption of Huntingtin-associated protein-1 (Hap1) results in postnatal death due to depressed feeding behaviorEdmond Y W Chan, Jamal Nasir, Claire-Anne Gutekunst, et al.
Cell|June 2, 1995
Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotesJ Nasir, S B Floresco, J R O'Kusky, et al.
Cardiovascular Diabetology|March 27, 2019
The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese ratJavad Habibi, Annayya R Aroor, Nitin A Das, et al.
British Journal of Clinical Pharmacology|March 21, 2017
Pharmacogenomic screening for anthracycline-induced cardiotoxicity in childhood cancerFolefac Aminkeng, Colin J D Ross, Shahrad R Rassekh, et al.
The Science of the Total Environment|November 17, 2018
Fate of pharmaceuticals in a spray-irrigation system: From wastewater to groundwaterFaith A Kibuye, Heather E Gall, Kyle R Elkin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 13, 1999
A frequent mutation in the lipoprotein lipase gene (D9N) deteriorates the biochemical and clinical phenotype of familial hypercholesterolemiaM E Wittekoek, E Moll, S N Pimstone, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 1, 1995
Patients with apoE3 deficiency (E2/2, E3/2, and E4/2) who manifest with hyperlipidemia have increased frequency of an Asn 291-->Ser mutation in the human LPL geneH Zhang, P W Reymer, M S Liu, et al.
Brain : a Journal of Neurology|August 18, 2024
Exon 1-targeting miRNA reduces the pathogenic exon 1 HTT protein in Huntington's disease modelsMarina Sogorb-Gonzalez, Christian Landles, Nicholas S Caron, et al.
Pageof 104

Showing results (711-720 of 1,032) with videos related to

Sort By:
Pageof 104
Journal of Molecular and Cellular Cardiology|July 1, 1996
Post-transcriptional regulation of extracellular matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathyS C Tyagi, S G Kumar, S J Haas, et al.
American Journal of Nephrology|October 5, 2007
Insulin resistance, oxidative stress, and podocyte injury: role of rosuvastatin modulation of filtration barrier injuryAdam Whaley-Connell, Vincent G DeMarco, Guido Lastra, et al.
Human Molecular Genetics|April 25, 2002
Targeted disruption of Huntingtin-associated protein-1 (Hap1) results in postnatal death due to depressed feeding behaviorEdmond Y W Chan, Jamal Nasir, Claire-Anne Gutekunst, et al.
Cell|June 2, 1995
Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotesJ Nasir, S B Floresco, J R O'Kusky, et al.
Cardiovascular Diabetology|March 27, 2019
The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese ratJavad Habibi, Annayya R Aroor, Nitin A Das, et al.
British Journal of Clinical Pharmacology|March 21, 2017
Pharmacogenomic screening for anthracycline-induced cardiotoxicity in childhood cancerFolefac Aminkeng, Colin J D Ross, Shahrad R Rassekh, et al.
The Science of the Total Environment|November 17, 2018
Fate of pharmaceuticals in a spray-irrigation system: From wastewater to groundwaterFaith A Kibuye, Heather E Gall, Kyle R Elkin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 13, 1999
A frequent mutation in the lipoprotein lipase gene (D9N) deteriorates the biochemical and clinical phenotype of familial hypercholesterolemiaM E Wittekoek, E Moll, S N Pimstone, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 1, 1995
Patients with apoE3 deficiency (E2/2, E3/2, and E4/2) who manifest with hyperlipidemia have increased frequency of an Asn 291-->Ser mutation in the human LPL geneH Zhang, P W Reymer, M S Liu, et al.
Brain : a Journal of Neurology|August 18, 2024
Exon 1-targeting miRNA reduces the pathogenic exon 1 HTT protein in Huntington's disease modelsMarina Sogorb-Gonzalez, Christian Landles, Nicholas S Caron, et al.
Pageof 104